Loading
Loading
Alnylam Pharmaceuticals ceo salary
Yvonne L. Greenstreet, M.D. Chief Executive Officer (principal executive officer) of Alnylam Pharmaceuticals, Inc. (ALNY), received $14,867,600 ($14.9M) in total compensation for FY2025, up 29.4% from the prior year. Stock awards of $5,512,500 were the largest component. Figures come from Alnylam Pharmaceuticals, Inc.'s DEF 14A filed 6 Apr 2026 (accession 0001628280-26-023923).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001628280-26-023923). These figures come from Alnylam Pharmaceuticals, Inc.'s DEF 14A filed 6 Apr 2026 (accession 0001628280-26-023923).
| Component | Amount |
|---|---|
| Salary | $1,404,200 |
| Stock awards | $5,512,500 |
| Option awards | $4,363,380 |
| Cash incentive | $3,562,500 |
| Other | $25,020 |
| Total | $14,867,600 |
FAQ
See also: ALNY ticker page